Prevalence, predictors and prognosis of post-stroke hyperglycaemia in acute stroke trials: individual patient data pooled analysis from the virtual international stroke trials archive (VISTA)

Keith W. Muir, Michael McCormick, Tracey Baird, Myzoon Ali

    Research output: Contribution to journalArticle

    Abstract

    Post-stroke hyperglycaemia (PSH) is associated with higher mortality and dependence, but further data on predictors of PSH and its evolution over time are required. We examined the prevalence, predictors, and prognosis of acute PSH using data from well-characterised clinical trials in the VISTA database. Methods: Data were extracted for individual participants enrolled ¿1 blood glucose readings documented. PSH was defined as glucose >7.0 mmol/l. Outcome measures were: (1) prevalence of PSH; (2) predictors of PSH by binary logistic regression; (3) mortality, and (4) favourable functional outcome [modified Rankin Scale (mRS) score

    Original languageEnglish
    Pages (from-to)17-27
    Number of pages11
    JournalCerebrovascular Diseases
    Volume1
    Issue number1
    Publication statusPublished - 1 Jan 2011

    Keywords

    • post-stroke hyperglycaemia
    • clinical trials
    • VISTA

    Fingerprint Dive into the research topics of 'Prevalence, predictors and prognosis of post-stroke hyperglycaemia in acute stroke trials: individual patient data pooled analysis from the virtual international stroke trials archive (VISTA)'. Together they form a unique fingerprint.

    Cite this